Eli Lilly to launch diabetes, obesity drug in India next year
NEW DELHI: Eli Lilly, the US pharmaceutical giant that gained widespread attention globally with its weight-loss treatments, plans to launch its blockbuster drug – Tirzepatide – in India in 2025.“India presents a promising market, with a large and growing population, rising disease burden from obesity, diabetes, and cancer, and an increasing health expenditure … A […]